The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Improving Primary Care for Patients With Chronic Illness
Bodenheimer, T. (2002) · JAMA · doi:10.1001/jama.288.14.1775 · Cited by 2,961
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778
Barr, V., Robinson, S., Marin-Link, B., Underhill, L., Dotts, A., Ravensdale, D., & Salivaras, S. (2003) · Healthcare Quarterly · doi:10.12927/hcq.2003.16763 · Cited by 686
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationMechanick, J. I., Youdim, A., Jones, D. B., Garvey, W. T., Hurley, D. L., McMahon, M. M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., et al. (2013) · Endocrine Practice · doi:10.4158/ep12437.gl · Cited by 395
Self-citationOrlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
Research works printed but not linked: 51
- Flegal, 2012, Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010, JAMA, 307, 491, 10.1001/jama.2012.39 · DOI
- Ogden, 2012, Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010, JAMA, 307, 483, 10.1001/jama.2012.40 · DOI
- Skinner, 2014, Prevalence and trends in obesity and severe obesity among children in the United States, 1999–2012, JAMA Pediatr, 168, 561, 10.1001/jamapediatrics.2014.21 · DOI · Paper page
- Cawley, 2012, The medical care costs of obesity: an instrumental variables approach, J Health Econ, 31, 219, 10.1016/j.jhealeco.2011.10.003 · DOI · Paper page
- Wang, 2008, Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic, Obesity (Silver Spring), 16, 2323, 10.1038/oby.2008.351 · DOI · Paper page
- Garvey, 2013, New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach, Endocr Pract, 19, 864, 10.4158/EP13263.RA · DOI
- Apovian, 2015, Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies, Obesity, 23, S1
- Cefalu, 2015, Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care editors' expert forum, Diabetes Care, 38, 1567, 10.2337/dc15-1081 · DOI
- Mechanick, 2012, American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine, Endocr Pract, 18, 642, 10.4158/EP12160.PS · DOI
- Garvey, 2014, American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on obesity: building an evidence base for comprehensive action, Endocr Pract, 20, 956, 10.4158/EP14279.CS · DOI
- Colman, 2012, Food and Drug Administration's Obesity Drug Guidance Document: a short history, Circulation, 125, 2156, 10.1161/CIRCULATIONAHA.111.028381 · DOI · Paper page
- Garber, 2015, AACE/ACE comprehensive diabetes management algorithm 2015, Endocr Pract, 21, 438, 10.4158/EP15693.CS · DOI · Paper page
- Jensen, 2014, 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, J Am Coll Cardiol, 63, 2985, 10.1016/j.jacc.2013.11.004 · DOI · Paper page
- Mechanick, 2004, American Association of Clinical Endocrinologists Ad Hoc Task Force for Standardized Production of Clinical Practice Guidelines. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines, Endocr Pract, 10, 353, 10.4158/EP.10.4.353 · DOI
- Mechanick, 2010, American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update, Endocr Pract, 16, 270, 10.4158/EP.16.2.270 · DOI
- Mechanick, 2014, American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2014 Update and the AACe G4G Program, Endocr Pract, 20, 692, 10.4158/EP14166.PS · DOI
- Gonzalez-Campoy, 2013, Endocr Pract, 19, 875, 10.4158/EP13155.ESGL · DOI
- Available at: http://www.cochranelibrary.com. [EL 4; NE]
- Colberg, 2010, Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes, Med Sci Sports Exerc, 42, 2282, 10.1249/MSS.0b013e3181eeb61c · DOI · Paper page
- Eckel, 2014, 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation, 129, S76
- Gonzalez-Campoy, 2013, Endocr Pract, 19, S1, 10.4158/EP13155.GL · DOI
- Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 · DOI · Paper page
- Gardner, 2010, Micronutrient quality of weight-loss diets that focus on macronutrients: results from the A TO Z study, Am J Clin Nutr, 92, 304, 10.3945/ajcn.2010.29468 · DOI · Paper page
- Buscemi, 2013, Effects of hypocaloric diets with different glycemic indexes on endothelial function and glycemic variability in overweight and in obese adult patients at increased cardiovascular risk, Clin Nutr, 32, 346, 10.1016/j.clnu.2012.10.006 · DOI
- Rizkalla, 2012, Differential effects of macronutrient content in 2 energy-restricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial, Am J Clin Nutr, 95, 49, 10.3945/ajcn.111.017277 · DOI
- Ebbeling, 2012, Effects of dietary composition on energy expenditure during weight-loss maintenance, JAMA, 307, 2627, 10.1001/jama.2012.6607 · DOI · Paper page
- Foreyt, 2009, Weight-reducing diets: are there any differences?, Nutr Rev, 67, S99, 10.1111/j.1753-4887.2009.00169.x · DOI
- Tirosh, 2013, Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial, Diabetes Care, 36, 2225, 10.2337/dc12-1846 · DOI · Paper page
- Muzio, 2007, Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome, Am J Clin Nutr, 86, 946, 10.1093/ajcn/86.4.946 · DOI
- Summer, 2011, Adiponectin changes in relation to the macronutrient composition of a weight-loss diet, Obesity (Silver Spring), 19, 2198, 10.1038/oby.2011.60 · DOI
- Bradley, 2009, Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial, Diabetes, 58, 2741, 10.2337/db09-0098 · DOI
- Brooking, 2012, Effects of macronutrient composition of the diet on body fat in indigenous people at high risk of type 2 diabetes, Diabetes Res Clin Pract, 96, 40, 10.1016/j.diabres.2011.11.021 · DOI
- Delbridge, 2009, One-year weight maintenance after significant weight loss in healthy overweight and obese subjects: does diet composition matter?, Am J Clin Nutr, 90, 1203, 10.3945/ajcn.2008.27209 · DOI
- Lim, 2010, Long-term effects of a low carbohydrate, low fat or high unsaturated fat diet compared to a no-intervention control, Nutr Metab Cardiovasc Dis, 20, 599, 10.1016/j.numecd.2009.05.003 · DOI · Paper page
- Lopez-Legarrea, 2014, The protein type within a hypocaloric diet affects obesity-related inflammation: the RESMENA project, Nutrition, 30, 424, 10.1016/j.nut.2013.09.009 · DOI
- Cheng, 2014, Influence of dietary macronutrient composition on eating behaviour and self-perception in young women undergoing weight management, Eat Weight Disord, 19, 241, 10.1007/s40519-014-0110-y · DOI
- Tang, 2013, Normal vs. high-protein weight loss diets in men: effects on body composition and indices of metabolic syndrome, Obesity (Silver Spring), 21, E204, 10.1002/oby.20078 · DOI
- Lasker, 2008, Moderate carbohydrate, moderate protein weight loss diet reduces cardiovascular disease risk compared to high carbohydrate, low protein diet in obese adults: a randomized clinical trial, Nutr Metab (Lond), 5, 30, 10.1186/1743-7075-5-30 · DOI
- Tapsell, 2010, Short term effects of energy restriction and dietary fat sub-type on weight loss and disease risk factors, Nutr Metab Cardiovasc Dis, 20, 317, 10.1016/j.numecd.2009.04.007 · DOI
- Mohammad, 2009, Effect of dietary macronutrient composition under moderate hypocaloric intake on maternal adaptation during lactation, Am J Clin Nutr, 89, 1821, 10.3945/ajcn.2008.26877 · DOI
- Buckland, 2009, Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study, Am J Epidemiol, 170, 1518, 10.1093/aje/kwp282 · DOI · Paper page
- Babio, 2014, Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial, CMAJ, 186, E649, 10.1503/cmaj.140764 · DOI
- Richard, 2013, Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome, Obesity (Silver Spring), 21, 51, 10.1002/oby.20239 · DOI
- Stendell-Hollis, 2013, A comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women, J Womens Health (Larchmt), 22, 48, 10.1089/jwh.2012.3707 · DOI
- Di Daniele, 2013, Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome, Acta Diabetol, 50, 409, 10.1007/s00592-012-0445-7 · DOI
- Richard, 2012, Effect of the Mediterranean diet with and without weight loss on surrogate markers of cholesterol homeostasis in men with the metabolic syndrome, Br J Nutr, 107, 705, 10.1017/S0007114511003436 · DOI
- Shai, 2010, Dietary intervention to reverse carotid atherosclerosis, Circulation, 121, 1200, 10.1161/CIRCULATIONAHA.109.879254 · DOI
- Greenway, 2010, Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial, Lancet, 376, 595, 10.1016/S0140-6736(10)60888-4 · DOI · Paper page
- Fidler, 2011, A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial, J Clin Endocrinol Metab, 96, 3067, 10.1210/jc.2011-1256 · DOI · Paper page
- Gadde, 2011, Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial, Lancet, 377, 1341, 10.1016/S0140-6736(11)60205-5 · DOI · Paper page
- Bodenheimer, 2014, The 10 building blocks of high-performing primary care, Ann Fam Med, 12, 166, 10.1370/afm.1616 · DOI
Cited by
Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O’Neil, P. M., Rubino, D. M., Skovgaard, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.1831 · Cited by 1,114
Self-citationWeight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over
Ryan, D. H., & Yockey, S. R. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0262-y · Cited by 831
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Malhotra, A., Grunstein, R. R., Fietze, I., Weaver, T. E., Redline, S., Azarbarzin, A., Sands, S. A., Schwab, R. J., Dunn, J. P., Chakladar, S., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2404881 · Cited by 871
O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. H. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31773-2 · Cited by 814
The science of obesity management: an endocrine society scientific statement
Bray, G. A., Heisel, W. E., Afshin, A., Jensen, M. D., Dietz, W. H., Long, M., Kushner, R. F., Daniels, S. R., Wadden, T. A., Tsai, A. G., et al. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00253 · Cited by 812
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Self-citationESPEN practical guideline: Clinical nutrition and hydration in geriatrics
Volkert, D., Beck, A. M., Cederholm, T., Cruz-Jentoft, A., Hooper, L., Kiesswetter, E., Maggio, M., Raynaud-Simon, A., Sieber, C., Sobotka, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.01.024 · Cited by 516
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Self-citationGarber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2017) · Endocrine Practice · doi:10.4158/ep161682.cs · Cited by 435
Self-citationHudgel, D. W., Patel, S. R., Ahasic, A. M., Bartlett, S. J., Bessesen, D. H., Coaker, M. A., Fiander, P. M., Grunstein, R. R., Gurubhagavatula, I., Kapur, V. K., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1326st · Cited by 266
Guideline Recommendations for Obesity Management
Ryan, D. H., & Kahan, S. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.006 · Cited by 221
Gaps to bridge: Misalignment between perception, reality and actions in obesity
Caterson, I. D., Alfadda, A. A., Auerbach, P., Coutinho, W., Cuevas, A., Dicker, D., Hughes, C., Iwabu, M., Kang, J., Nawar, R., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13752 · Cited by 210
Bray, G. A. (2023) · Nutrients · doi:10.3390/nu15102254 · Cited by 210
Kang, J. H., & Le, Q. A. (2017) · Medicine · doi:10.1097/md.0000000000008632 · Cited by 183
Locatelli, J. C., Costa, J. G., Haynes, A., Naylor, L. H., Fegan, P. G., Yeap, B. B., & Green, D. J. (2024) · Diabetes Care · doi:10.2337/dci23-0100 · Cited by 152
Nutritional considerations with antiobesity medications
Almandoz, J. P., Wadden, T. A., Tewksbury, C., Apovian, C. M., Fitch, A., Ard, J. D., Li, Z., Richards, J., Butsch, W. S., Jouravskaya, I., et al. (2024) · Obesity · doi:10.1002/oby.24067 · Cited by 134
Castro Sweet, C. M., Chiguluri, V., Gumpina, R., Abbott, P., Madero, E. N., Payne, M., Happe, L., Matanich, R., Renda, A., & Prewitt, T. (2018) · Journal of Aging and Health · doi:10.1177/0898264316688791 · Cited by 130
Ji, L., Jiang, H., Cheng, Z., Qiu, W., Liao, L., Zhang, Y., Li, X., Pang, S., Zhang, L., Chen, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44067-4 · Cited by 118
The incretin/glucagon system as a target for pharmacotherapy of obesity
Del Prato, S., Gallwitz, B., Holst, J. J., & Meier, J. J. (2022) · Obesity Reviews · doi:10.1111/obr.13372 · Cited by 77
Persistence of newer anti-obesity medications in a real-world setting
Ganguly, R., Tian, Y., Kong, S. X., Hersloev, M., Hobbs, T., Smolarz, B. G., Ramasamy, A., Haase, C. L., & Weng, W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.017 · Cited by 68
Impact of GLP-1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia
Memel, Z., Gold, S. L., Pearlman, M., Muratore, A., & Martindale, R. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00649-w · Cited by 63
Janssen, L. G. M., Nahon, K. J., Bracké, K. F. M., van den Broek, D., Smit, R., Sardjoe Mishre, A. S. D., Koorneef, L. L., Martinez-Tellez, B., Burakiewicz, J., Kan, H. E., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154167 · Cited by 54
Suissa, K., Schneeweiss, S., Kim, D. W., & Patorno, E. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14367 · Cited by 41
Guo, F., & Garvey, W. T. (2017) · Diabetes Care · doi:10.2337/dc17-0088 · Cited by 37
Self-citationPantalone, K. M., Smolarz, B. G., Ramasamy, A., Baz Hecht, M., Harty, B. J., Rogen, B., Griebeler, M. L., Borukh, E., Young, J. B., & Burguera, B. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16595 · Cited by 31
Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G. (2023) · Nutrients · doi:10.3390/nu15163582 · Cited by 27
Evaluation of multidisciplinary weight loss shared medical appointments
Yager, S., Parker, M., Luxenburg, J., & Varghai, N. H. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.07.014 · Cited by 14
Miazgowski, T., Kaczmarkiewicz, A., Miazgowski, B., & Kopeć, J. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01415-1 · Cited by 12
GLP-1 receptor agonist use does not increase risk of respiratory complications post-endoscopy
Velji-Ibrahim, J., Nathani, P., Patel, H. K., & Sharma, P. (2025) · Endoscopy International Open · doi:10.1055/a-2487-2937 · Cited by 6
Metadata
- Authors
- Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R.
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 22
- Issue
- 7
- Pages
- 842-884
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W4253617746
- Cited by
- 283
- References
- 19
- FWCI
- 25.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.